Ben Gillis

Director, Market Access at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Ben Gillis's Colleagues at Alnylam Pharmaceuticals
Lori Crane

Associate Director, Space Planning, Facilities, Real Estate and Engineering

Contact Lori Crane

John Szeto

Senior Associate Scientist

Contact John Szeto

Ryan Thomas

Senior Manager, External Quality

Contact Ryan Thomas

Maxwell Lasko

Clinical Pharmacologist

Contact Maxwell Lasko

Maged Darwish

Vice President, Global Regulatory Affairs, CMC

Contact Maged Darwish

Deirdre Parsons

Senior Director, Global Public Policy & Government Relations

Contact Deirdre Parsons

View All Ben Gillis's Colleagues
Ben Gillis's Contact Details
HQ
(617) 551-8200
Location
Boston, Massachusetts, United States
Company
Alnylam Pharmaceuticals
Ben Gillis's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Ben Gillis
Ben Gillis currently works for Alnylam Pharmaceuticals.
Ben Gillis's role at Alnylam Pharmaceuticals is Director, Market Access.
Ben Gillis's email address is ***@alnylam.com. To view Ben Gillis's full email address, please signup to ConnectPlex.
Ben Gillis works in the SaaS industry.
Ben Gillis's colleagues at Alnylam Pharmaceuticals are Lori Crane, John Szeto, Ryan Thomas, Maxwell Lasko, Maged Darwish, Kevin FitzGerald, Deirdre Parsons and others.
Ben Gillis's phone number is (617) 551-8200
See more information about Ben Gillis